“In silico Study of New Five-Membered Heterocyclic Derivatives Bearing (1,3,4-oxadiazole and 1,3,4-thiadiazole) As Promising Cyclooxygenase Inhibitors” (2024) Al Mustansiriyah Journal of Pharmaceutical Sciences, 24(3), pp. 237–251. doi:10.32947/ajps.v24i3.1060.